To determine the prevalence and distribution of pain in patients with Charcot-Marie-Tooth disease and the effects of surgery on this pain.
Members of the Charcot -Marie -Tooth International support group were sent a pain questionnaire. Data about the site, nature, frequency, severity of pain, pain triggers, methods of pain relief and the response to surgery were collected.
There were 399 respondents (233 women and 166 men). The most frequently reported sites of pain were the legs (79%) and feet (77%). Ankle pain was reported by 57%. Walking and exercise were the most frequent pain triggers. Rest was the most common method of modifying pain (60 % of respondents). 32 % found analgesics effective and 39% used heat to relive their pain. The most common sites for surgery were the foot (36%) and ankle (26%). In 43% of patients undergoing foot surgery and 54% of patients undergoing ankle surgery, pain had been increased or introduced following surgery.
Patients with Charcot-Marie-Tooth disease experience significant inherent, and probably neuropathic, pain in addition to pain from mechanical causes. Surgery is unlikely to improve or eliminate pain in these patients. It may introduce pain in some. Surgery should be confined to the treatment of structural problems, as it is often ineffective at relieving pain.
We report the results of seventy-six Harris Galante Porous Cups (HGP 1) in sixty-three patients treated by Total Hip Arthroplasty (THA) with a diagnosis of avascular necrosis (AVN) of the femur (grade III and IV). The cups were inserted between 1986 and 1994 and followed prospectively. Seventy hips with a follow up of more than five years (mean 7.6 years) were reviewed. At last review the mean Harris Hip Score was 94 (standard deviation (&
dcl001;) .8), preoperatively the mean had been 29 (&
dcl001;14.7). Radiographically there was no evidence of acetabular migration. The revision rate of the femoral prosthesis was 8.6%, however only three stems (4.3%) were revised for loosening the rest being revised to allow down sizing of the femoral head. The revision rate for the acetabular prosthesis was 7.1%, (five cups). At the time of revision none of the cups were clinically loose and only required the liner to be changed. The complication rate was low with no deep infections or dislocations and only nine hips, (11.8%) with grade III heterotopic ossification. Survival analysis for both stem and cup at 8 years is 96.3% (confidence interval 91 – 100%), with a worst-case survival of 93.6%, (C.I 87.4 – 99.9%) Previous studies of patients undergoing cemented THA for the treatment of advanced AVN have reported a high incidence of component loosening. This study shows good medium term results using the Harris Galante Porous cup for acetabular reconstruction with cemented femoral components for the treatment of this difficult problem.
This study assesses the clinical performance of the Souter-Strathclyde elbow arthroplasty with a standardised index and long term survivorship analysis. We undertook assessment of 68 primary Souter-Strathclyde total elbow replacements. Of 53 patients assessed with pre-operative Souter-Strathclyde charts, nine died and one was lost to follow-up, 43 had radiographic and telephone review, and 38 (88%) had clinical examination according to the Mayo Elbow Performance Index. Survival of the 43 elbows was to a mean of 72 months (range: eight to 187 months) with improvement in pain, motion, stability and function. Eight of 10 elbows in deceased patients had satisfactory scores at the last assessment. Ulnar neuropraxia occurred in eight elbows (12%), persistent sensory deficit in two (3%) and motor deficit in one. Two triceps abscesses required local skin flap cover. Revision was undertaken in 14 elbows (20%) for instability (six) bony injury (three), loosening (three) and intraoperative problems (two). The survivorship at 13 years was 74% with 62 (91%) of all elbows achieving a satisfactory Mayo score.
